Designing personalized cancer nanomedicines is a challenging process. The emerging field of nanoinformatics can facilitate this process by enabling computational design of nanocarrier-encapsulated drugs. Recent data show that quantitative structure–nanoparticle assembly calculations predict particle formation and size, and can lead to safer and more effective personalized cancer therapeutics.
Bibliographical notePublisher Copyright:
© 2018 Elsevier Inc.
- caveolin-mediated endocytosis
- machine learning
- tyrosine kinase inhibitors